CN101688246B - 用于昆虫细胞的合成的表达载体 - Google Patents
用于昆虫细胞的合成的表达载体 Download PDFInfo
- Publication number
- CN101688246B CN101688246B CN200880021845.1A CN200880021845A CN101688246B CN 101688246 B CN101688246 B CN 101688246B CN 200880021845 A CN200880021845 A CN 200880021845A CN 101688246 B CN101688246 B CN 101688246B
- Authority
- CN
- China
- Prior art keywords
- expression
- sequence
- cell
- promoter
- synthetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013604 expression vector Substances 0.000 title claims abstract description 99
- 241000238631 Hexapoda Species 0.000 title claims abstract description 52
- 230000014509 gene expression Effects 0.000 claims abstract description 194
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 159
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 101
- 230000028327 secretion Effects 0.000 claims abstract description 44
- 235000013399 edible fruits Nutrition 0.000 claims description 78
- 108091026898 Leader sequence (mRNA) Proteins 0.000 claims description 24
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 22
- 230000003248 secreting effect Effects 0.000 claims description 14
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 238000003780 insertion Methods 0.000 claims description 3
- 230000037431 insertion Effects 0.000 claims description 3
- 101000709694 Margaritifera margaritifera Putative chitinase 2 Proteins 0.000 claims 1
- 101000942926 Pinctada maxima Putative chitinase Proteins 0.000 claims 1
- 108091036066 Three prime untranslated region Proteins 0.000 abstract description 39
- 239000000203 mixture Substances 0.000 abstract description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 5
- 229960005486 vaccine Drugs 0.000 abstract description 2
- 239000013598 vector Substances 0.000 abstract 3
- 108091006106 transcriptional activators Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 153
- 235000018102 proteins Nutrition 0.000 description 70
- 230000001276 controlling effect Effects 0.000 description 59
- 239000002773 nucleotide Substances 0.000 description 48
- 125000003729 nucleotide group Chemical group 0.000 description 48
- 239000000047 product Substances 0.000 description 40
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 35
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 35
- 238000013461 design Methods 0.000 description 25
- 101150111648 mtnA gene Proteins 0.000 description 24
- 108020004999 messenger RNA Proteins 0.000 description 22
- 108020004414 DNA Proteins 0.000 description 20
- 102100022808 Kielin/chordin-like protein Human genes 0.000 description 20
- 238000000034 method Methods 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 19
- 108091026908 Downstream promoter element Proteins 0.000 description 18
- 230000001131 transforming effect Effects 0.000 description 14
- 238000011144 upstream manufacturing Methods 0.000 description 14
- 241000256186 Anopheles <genus> Species 0.000 description 13
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 13
- 238000003776 cleavage reaction Methods 0.000 description 13
- 238000005457 optimization Methods 0.000 description 13
- 230000007017 scission Effects 0.000 description 13
- 239000013613 expression plasmid Substances 0.000 description 12
- 238000012045 magnetic resonance elastography Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 10
- 241001123946 Gaga Species 0.000 description 9
- 150000001413 amino acids Chemical group 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 8
- 108091035707 Consensus sequence Proteins 0.000 description 8
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 description 8
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 description 8
- 102000003792 Metallothionein Human genes 0.000 description 8
- 108090000157 Metallothionein Proteins 0.000 description 8
- 108700008625 Reporter Genes Proteins 0.000 description 8
- 108700026226 TATA Box Proteins 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 230000008488 polyadenylation Effects 0.000 description 8
- 241000255789 Bombyx mori Species 0.000 description 7
- 108020004705 Codon Proteins 0.000 description 7
- 108091023040 Transcription factor Proteins 0.000 description 7
- 102000040945 Transcription factor Human genes 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 230000002068 genetic effect Effects 0.000 description 7
- 230000035897 transcription Effects 0.000 description 7
- 238000013518 transcription Methods 0.000 description 7
- 241000701447 unidentified baculovirus Species 0.000 description 7
- 239000012190 activator Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
- 241000701022 Cytomegalovirus Species 0.000 description 5
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 5
- 241000700605 Viruses Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 230000027455 binding Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 229930182817 methionine Natural products 0.000 description 5
- 230000002103 transcriptional effect Effects 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 230000014621 translational initiation Effects 0.000 description 5
- 102000012286 Chitinases Human genes 0.000 description 4
- 108010022172 Chitinases Proteins 0.000 description 4
- 241000255601 Drosophila melanogaster Species 0.000 description 4
- 101100099925 Drosophila melanogaster Tollo gene Proteins 0.000 description 4
- 108700009124 Transcription Initiation Site Proteins 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000002441 reversible effect Effects 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- 241000288673 Chiroptera Species 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000206602 Eukaryota Species 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 108010057081 Merozoite Surface Protein 1 Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 108700029229 Transcriptional Regulatory Elements Proteins 0.000 description 3
- 102000004504 Urokinase Plasminogen Activator Receptors Human genes 0.000 description 3
- 108010042352 Urokinase Plasminogen Activator Receptors Proteins 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- YQYJSBFKSSDGFO-FWAVGLHBSA-N hygromycin A Chemical compound O[C@H]1[C@H](O)[C@H](C(=O)C)O[C@@H]1Oc1ccc(\C=C(/C)C(=O)N[C@@H]2[C@@H]([C@H]3OCO[C@H]3[C@@H](O)[C@@H]2O)O)cc1O YQYJSBFKSSDGFO-FWAVGLHBSA-N 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 210000004962 mammalian cell Anatomy 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000004940 nucleus Anatomy 0.000 description 3
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 3
- 230000004481 post-translational protein modification Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000005026 transcription initiation Effects 0.000 description 3
- 230000003612 virological effect Effects 0.000 description 3
- UTZAFOQPCXRRFF-RKBILKOESA-N (beta-D-glucosyl)-O-mycofactocinone Chemical compound CC1(C(NC(=O)C1=O)CC2=CC=C(C=C2)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C UTZAFOQPCXRRFF-RKBILKOESA-N 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 2
- 108010085238 Actins Proteins 0.000 description 2
- 241000256182 Anopheles gambiae Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 101100258233 Caenorhabditis elegans sun-1 gene Proteins 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 101100024583 Mus musculus Mtf1 gene Proteins 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 241000223960 Plasmodium falciparum Species 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 108091027981 Response element Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 108090000941 Transcription factor TFIIB Proteins 0.000 description 2
- 102000004408 Transcription factor TFIIB Human genes 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 230000009089 cytolysis Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 210000003527 eukaryotic cell Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 210000000630 fibrocyte Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000002940 repellent Effects 0.000 description 2
- 239000005871 repellent Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 239000009871 tenuigenin Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000003146 transient transfection Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101150084750 1 gene Proteins 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 241000409811 Bombyx mori nucleopolyhedrovirus Species 0.000 description 1
- 101100228200 Caenorhabditis elegans gly-5 gene Proteins 0.000 description 1
- 101100243951 Caenorhabditis elegans pie-1 gene Proteins 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 101150082297 Clp gene Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- CTENFNNZBMHDDG-UHFFFAOYSA-N Dopamine hydrochloride Chemical compound Cl.NCCC1=CC=C(O)C(O)=C1 CTENFNNZBMHDDG-UHFFFAOYSA-N 0.000 description 1
- 102100025800 E3 SUMO-protein ligase ZBED1 Human genes 0.000 description 1
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101150039660 HA gene Proteins 0.000 description 1
- LYCVKHSJGDMDLM-LURJTMIESA-N His-Gly Chemical compound OC(=O)CNC(=O)[C@@H](N)CC1=CN=CN1 LYCVKHSJGDMDLM-LURJTMIESA-N 0.000 description 1
- 101000786317 Homo sapiens E3 SUMO-protein ligase ZBED1 Proteins 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 238000012356 Product development Methods 0.000 description 1
- 108010022052 Proprotein Convertase 5 Proteins 0.000 description 1
- 102000012210 Proprotein Convertase 5 Human genes 0.000 description 1
- 101150056766 Tollo gene Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 101150094147 bat gene Proteins 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 210000004900 c-terminal fragment Anatomy 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000013599 cloning vector Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005558 fluorometry Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010036413 histidylglycine Proteins 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000012846 protein folding Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000000518 sarcolemma Anatomy 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000004960 subcellular localization Effects 0.000 description 1
- 229940031626 subunit vaccine Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
- 238000002424 x-ray crystallography Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/103—Plasmid DNA for invertebrates
- C12N2800/105—Plasmid DNA for invertebrates for insects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/75—Vector systems having a special element relevant for transcription from invertebrates
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (10)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92662107P | 2007-04-26 | 2007-04-26 | |
US60/926,621 | 2007-04-26 | ||
PCT/US2008/005514 WO2008134068A2 (en) | 2007-04-26 | 2008-04-28 | Synthetic expression vectors for insect cells |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101688246A CN101688246A (zh) | 2010-03-31 |
CN101688246B true CN101688246B (zh) | 2013-09-25 |
Family
ID=39926276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880021845.1A Active CN101688246B (zh) | 2007-04-26 | 2008-04-28 | 用于昆虫细胞的合成的表达载体 |
Country Status (7)
Country | Link |
---|---|
US (1) | US8198079B2 (zh) |
EP (1) | EP2147121B1 (zh) |
JP (1) | JP5345135B2 (zh) |
CN (1) | CN101688246B (zh) |
AU (1) | AU2008246139B2 (zh) |
BR (1) | BRPI0811053B1 (zh) |
WO (1) | WO2008134068A2 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2404382B (en) | 2003-07-28 | 2008-01-30 | Oxitec Ltd | Pest control |
GB2443186A (en) | 2006-10-25 | 2008-04-30 | Oxitec Ltd | Expression system for mediating alternative splicing |
EP2620446A1 (en) | 2012-01-27 | 2013-07-31 | Laboratorios Del Dr. Esteve, S.A. | Immunogens for HIV vaccination |
GB2500113A (en) * | 2012-03-05 | 2013-09-11 | Oxitec Ltd | Arthropod male germline gene expression system |
GB201303932D0 (en) | 2013-03-05 | 2013-04-17 | Oxitec Ltd | Muscle actin promoter |
GB2526867A (en) | 2014-06-05 | 2015-12-09 | Oxitec Ltd | Gene expression system |
US10016514B2 (en) | 2015-05-15 | 2018-07-10 | New Hope Research Foundation | Polynucleotides, vectors and methods for insertion and expression of transgenes |
US11827876B2 (en) | 2016-08-12 | 2023-11-28 | Oxitec Ltd. | Self-limiting, sex-specific gene and methods of using |
ES2924261T3 (es) * | 2017-04-19 | 2022-10-05 | Medimmune Ltd | Diseño informático de promotores de mamíferos con funcionalidad definida por el usuario |
CN107937437B (zh) * | 2017-11-22 | 2020-10-27 | 中国科学院武汉物理与数学研究所 | 一种昆虫细胞的光控表达载体及应用 |
IL257269A (en) * | 2018-01-31 | 2018-04-09 | Olender Tsviya | Signaling is directed to the endoplasmic reticulum |
CN109295056A (zh) * | 2018-09-10 | 2019-02-01 | 天津大学 | 一种天蓝色链霉菌双向启动子scp1 |
AU2020384323A1 (en) | 2019-11-14 | 2022-06-02 | Aelix Therapeutics, S.L. | Dosage regimens for vaccines |
WO2022232049A1 (en) * | 2021-04-26 | 2022-11-03 | The Regents Of The University Of California | High-throughput expression-linked promoter selection in eukaryotic cells |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060228400A1 (en) * | 2001-12-28 | 2006-10-12 | Syngenta Participations Ag | Thermotolerant phytase for animal feed |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5244805A (en) * | 1989-05-17 | 1993-09-14 | University Of Georgia Research Foundation, Inc. | Baculovirus expression vectors |
US7968698B2 (en) | 2005-05-25 | 2011-06-28 | The Regents Of The University Of California | Optimized core promoters and uses thereof |
WO2007022425A2 (en) | 2005-08-16 | 2007-02-22 | Hawaii Biotech, Inc. | Influenza recombinant subunit vaccine |
-
2008
- 2008-04-28 JP JP2010506302A patent/JP5345135B2/ja active Active
- 2008-04-28 CN CN200880021845.1A patent/CN101688246B/zh active Active
- 2008-04-28 WO PCT/US2008/005514 patent/WO2008134068A2/en active Application Filing
- 2008-04-28 BR BRPI0811053-0A patent/BRPI0811053B1/pt active IP Right Grant
- 2008-04-28 EP EP08754138.9A patent/EP2147121B1/en active Active
- 2008-04-28 US US12/451,145 patent/US8198079B2/en active Active
- 2008-04-28 AU AU2008246139A patent/AU2008246139B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060228400A1 (en) * | 2001-12-28 | 2006-10-12 | Syngenta Participations Ag | Thermotolerant phytase for animal feed |
Non-Patent Citations (2)
Title |
---|
Matsumoto K 等.Necdin acts as a transcriptional repressor that interacts with multiple guanosine clusters.《Gene》.2001,第272卷(第1-2期), * |
Teunissen B E J 等.Analysis of the rat connexin 43 proximal promoter in neonatal cardiomyocytes.《Gene》.2003,第322卷 * |
Also Published As
Publication number | Publication date |
---|---|
AU2008246139A1 (en) | 2008-11-06 |
WO2008134068A2 (en) | 2008-11-06 |
WO2008134068A3 (en) | 2009-01-29 |
JP5345135B2 (ja) | 2013-11-20 |
JP2010524501A (ja) | 2010-07-22 |
US20100167389A1 (en) | 2010-07-01 |
US8198079B2 (en) | 2012-06-12 |
CN101688246A (zh) | 2010-03-31 |
EP2147121B1 (en) | 2014-12-17 |
BRPI0811053B1 (pt) | 2019-03-06 |
AU2008246139B2 (en) | 2013-11-21 |
BRPI0811053A2 (pt) | 2015-01-27 |
EP2147121A4 (en) | 2011-09-14 |
EP2147121A2 (en) | 2010-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101688246B (zh) | 用于昆虫细胞的合成的表达载体 | |
JP6831797B2 (ja) | メチロトローフ酵母の遺伝子操作の発現構築物および方法 | |
JP5925407B2 (ja) | ヒト細胞系における組換えヒトタンパク質の無血清安定トランスフェクションおよび製造 | |
JP2008527985A (ja) | 糸状菌細胞において目的の化合物を産生させるための方法 | |
CN106978441A (zh) | 生产蛋白质的方法 | |
US20080057538A1 (en) | Chaperone expression genomes | |
Hong et al. | Genetic engineering of baculovirus-insect cell system to improve protein production | |
JP2022529021A (ja) | タンパク質作製の材料および方法 | |
US20220042040A1 (en) | Dual vector system for improved production of proteins in animal cells | |
Arya et al. | Dictyostelium discoideum—a promising expression system for the production of eukaryotic proteins | |
Shen et al. | Recombinant DNA technology and cell line development | |
Yamaji et al. | Production of Japanese encephalitis virus-like particles in insect cells | |
WO2016003368A1 (en) | Optimized vectors for the production of recombinant proteins | |
Jarvis | Foreign gene expression in insect cells | |
JP4613160B2 (ja) | 軽度の低温により遺伝子の発現を促進させる配列 | |
EP1967585B1 (en) | Method for gene amplification | |
AU2017301918A1 (en) | Optimized Zika virus envelope gene and expression thereof | |
US20220025422A1 (en) | Improved Filamentous Fungal Host Cells | |
DK2646558T3 (en) | Promoters for expression of genes in a fungal cell | |
Eibl et al. | Insect cell-based recombinant protein production | |
US9127285B2 (en) | Genetically altered ciliates and uses thereof | |
JP2023501619A (ja) | 非ウイルス転写活性化ドメイン並びにそれに関連する方法及び使用 | |
CN1748034A (zh) | 改进的表达元件 | |
Jones | Insect viruses | |
KR20180065292A (ko) | 곤충세포를 이용한 재조합 오스모틴 단백질의 생산방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: MSD CORP. Free format text: FORMER OWNER: HAWAII BIOTECH INC. Effective date: 20130822 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130822 Address after: American New Jersey Applicant after: MERCK SHARP & DOHME Corp. Address before: Hawaii USA Applicant before: HAWAII BIOTECH, Inc. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220823 Address after: New Jersey USA Patentee after: MERCK SHARP & DOHME B.V. Address before: New Jersey USA Patentee before: MERCK SHARP & DOHME Corp. |